Erica Joyner – Page 10 – In The States

Michigan

Medicaid issued a bulletin announcing prescription copay change for Healthy Michigan Plan enrollees.

Also in Michigan, The Department of Licensing and Regulatory Affairs (LARA) issued an email communication to pharmacies regarding the new Pharmacy Technician Administrative Rules that were effective on Oct. 2, 2023. They noted they are diligently working on updating relative information on their website to reflect the revision. Please send questions about the revised rules to BPLHELP@michigan.gov.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2023-12-08T10:03:46-05:00December 8, 2023|Michigan|

Minnesota

The Secretary of State announced open positions on the Prescription Drug Affordability Board (PDAB) and the PDAB Advisory Council. Applications may be submitted on the Open Positions page. If you are interested in applying, please contact NACDS’ Jill McCormack to coordinate.

Also in Minnesota, the Department of Health (MDH) has opened registration to all manufacturers, wholesalers, pharmacies, and pharmacy benefit managers required to submit prescription drug price transparency reports. Beginning in 2024, prescription drug manufacturers, pharmacies, wholesalers, and pharmacy benefit managers will be required to report quarterly on drugs of substantial public interest identified by MDH. All reporting entities are required to register with MDH’s online reporting system beginning January 1, 2024. MDH’s guide to registering provides more detail on the process.

Upcoming Implementation Steps:

January 1, 2024: registration requirement goes into effect
By January 31, 2024: MDH releases the first list of drugs of substantial public interest for reporting
Thirty (30) or more days after the drug list is posted, MDH will notify reporting entities of their reporting obligations; reporting entities have 60 days after the notification is sent to report
Early 2024: MDH will release finalized reporting guidance

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2023-12-08T10:02:56-05:00December 8, 2023|Minnesota|

Missouri

The Board of Pharmacy hosted a webinar providing new information on the Prescription Drug Monitor Program (PDMP).

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2023-12-08T10:01:41-05:00December 8, 2023|Missouri|

Montana

The Board of Pharmacy and the Board of Veterinary Medicine posted the Joint Full Board Meeting Agenda for December 7. The meeting will be held by teleconference only; see agenda for details. Information is available on the Board meetings page.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2023-12-08T10:01:04-05:00December 8, 2023|Montana|

Nebraska

The Department of Health and Human Services issued Provider Bulletin 23-31: Hepatitis C Virus (HCV) Antiviral Treatment to notify Medicaid providers of upcoming changes to HCV antiviral treatment requirements.

Also in Nebraska, the Department of Health and Human Services issued Provider Bulletin 32-30: Claims for Reinstated Medicaid Members to inform Medicaid providers of members whose coverage has been reinstated due to recent federal guidance. Additional information on Medicaid member reimbursement is also available online, including copays for prescription drugs paid to pharmacies.

Finally in Nebraska, the Department of Health and Human Services posted the draft minutes from the November 14 Drug Utilization Review Board meeting. The next meeting will be held on January 9, 2024.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Erica Joyner2023-12-08T10:00:27-05:00December 8, 2023|Nebraska|

Nevada

The next meeting of the Board of Pharmacy will be in Las Vegas on December 6 and 7.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2023-12-08T09:55:59-05:00December 8, 2023|Nevada|

New York

Effective November 29, the New York Department of Health issued updated guidance regarding dispensing of COVID-19 over-the-counter tests at the pharmacy.

NYRx, the New York State Medicaid Pharmacy Benefit Program, sent a release to pharmacy providers on December 6^th. The program continues to field questions and concerns from residency program coordinators about pharmacies not able to submit claims to NYRx written by their interns and residents. NYRx asked the following shared regarding submission of claims:

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Erica Joyner2023-12-08T09:55:28-05:00December 8, 2023|New York|

Ohio

The Board of Pharmacy has issued the following communications:

Also in Ohio, the Senate passed SB 144 by a vote of 30-1. This is a priority bill for pharmacy that would permanently authorized pharmacists and both certified and registered technicians to administer all vaccines to patients aged five and older. Action in the House is expected in 2024.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Erica Joyner2023-12-08T09:54:38-05:00December 8, 2023|Ohio|

Oklahoma

The Bureau of Narcotics and Dangerous Drugs (OBN) alerted the Board of Pharmacy of the ongoing cyberattack regarding Ardent Health Services that is affecting multiple facilities in the state including Hillcrest Health System, Bailey Medical Center, and Utica Park Clinics, among others. The Board issued guidance for pharmacies that receive prescriptions for controlled substances from Ardent Health providers to continue filling the prescriptions received while continuing due diligence in confirming the prescription itself is valid and accurate, regardless of the manner or media received. This is a temporary solution to ensure prescribers can continue patient care until they can obtain OBN prescription pads.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Erica Joyner2023-12-08T09:53:42-05:00December 8, 2023|Oklahoma|

About Erica Joyner